Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy-Reference-Cited by-同舟云学术

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy

Published:2020 Issue:1 Volume:63 Page:55
ISSN:2287-8572
Container-title:Obstetrics & Gynecology Science
language:en
Short-container-title:Obstet Gynecol Sci

Author:

Jeerakornpassawat Dhammapoj¹,Suprasert Prapaporn¹^ORCID

Affiliation:

1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Publisher

Korean Society of Obstetrics and Gynecology

Subject

Obstetrics and Gynecology

Link

https://synapse.koreamed.org/pdf/10.5468/ogs.2020.63.1.55

Reference14 articles.

1. International Agency for Research on Cancer. Estimated number of new cases in 2018, worldwide, females [Internet]. Lyon. International Agency for Research on Cancer. 2018. cited 2019 Aug 1. Available from: http://gco.iarc.fr/today/online-analysis-table?v=2018&mode=cancer&mode_population=continents&population=900&populations=900&key=asr&sex=2&cancer=39&type=0&statistic=5&prevalence=0&population_group=0&ages_group%5B%5D=10&ages_group%5B%5D=15&nb_items=5&group_cancer=1&include_nmsc=1&include_nmsc_other=1

2. Ovarian cancer

3. Treatment of recurrent ovarian cancer

4. Neutrophils in cancer: prognostic role and therapeutic strategies

5. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio before chemotherapy as potential prognostic factors in patients with newly diagnosed epithelial ovarian cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils;2024-08-07

2. Prognostic value of neutrophil-to-lymphocyte ratio and fibrinogen levels in ovarian cancer;Medical Journal of Indonesia;2023-10-02

3. Serum CA125 level as predictors of the efficacy of olaparib maintenance therapy for platinum‐sensitive relapsed ovarian cancer;Journal of Obstetrics and Gynaecology Research;2023-09-21

4. Prognostic value of preoperative serological biomarkers in patients undergoing cytoreductive surgery for ovarian cancer peritoneal metastases;Pleura and Peritoneum;2023-05-16

5. Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR;Journal of Ovarian Research;2023-02-09